Extended Follow-up from the Stereotactic Body Radiotherapy for High-risk Localized Carcinoma of the Prostate (SHARP) Consortium: Updated Analysis of 440 Patients

By afschroeder • April 13, 2026

Valle LF, Romero-Kalbasi T, Jiang T, van Dams R, Fuller DB, Loblaw A, Kennedy T, Collins SP, Sharma V, Suy S, Murthy V, Mallick I, Nickols NG, Desai N, Hannan R, Aghdam N, Kaplan ID, Stephans K, Tendulkar R, Lau S, Taparra K, Steinberg ML, Kishan AU. Extended Follow-up from the Stereotactic Body Radiotherapy for High-risk Localized Carcinoma of the Prostate (SHARP) Consortium: Updated Analysis of 440 Patients. Eur Urol Oncol. 2026 Apr 10:S2588-9311(26)00078-7. doi: 10.1016/j.euo.2026.03.019. Epub ahead of print. PMID: 41966956.

Tags: DOM STAT, Dose escalation, General Internal Medicine, High-risk prostate cancer, hormone therapy, Publications, Radiotherapy, SBRT, Stereotactic body radiotherapy

Comparative analysis of NSG and NBSGW mice for preclinical evaluation of gene-modified human hematopoietic stem and progenitor cells

Kuo CY, Harrington S, Campo-Fernandez B, Wyman SK, Wu X, Zhang R, Espinoza A, de Andrade Silva BJ, Sanchez JM, Fitz-Gibbon S, Tseng CH, Pellegrini[...]

Experiential Avoidance is Associated with Insomnia Symptoms and Related Consequences Among Veterans with Posttraumatic Stress Disorder

Carlson GC, Gold AI, Erickson AJ, Kelly MR, Mitchell MN, Josephson KR, Carlson KJ, McGowan SK, MacCabe CHG, Zeidler MR, Fung CH, Alessi CA, Yano[...]

Hair follicle immune privilege in autoimmune and immune-mediated alopecias: paths toward reestablishing immune tolerance

Shafiei-Jahani P, Li X, Akbari A, Haniff E, Ziprick M, Carlisle R, Goh C, Holland V, Akbari O. Hair follicle immune privilege in autoimmune and[...]